These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 9892207)
1. Cyclooxygenase-2 expression in human esophageal carcinoma. Zimmermann KC; Sarbia M; Weber AA; Borchard F; Gabbert HE; Schrör K Cancer Res; 1999 Jan; 59(1):198-204. PubMed ID: 9892207 [TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945 [TBL] [Abstract][Full Text] [Related]
4. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617 [TBL] [Abstract][Full Text] [Related]
5. Expression of cyclo-oxygenase-2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squamous cell carcinomas. Kase S; Osaki M; Honjo S; Adachi H; Tsujitani S; Kaibara N; Ito H Virchows Arch; 2003 Feb; 442(2):129-35. PubMed ID: 12596063 [TBL] [Abstract][Full Text] [Related]
6. Molecular pathology of cyclooxygenase-2 in neoplasia. Fosslien E Ann Clin Lab Sci; 2000 Jan; 30(1):3-21. PubMed ID: 10678579 [TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma. Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472 [TBL] [Abstract][Full Text] [Related]
8. [Expression of cyclooxygenase-2 in esophageal squamous cell carcinogenesis]. Yu HP; Liu L; Shi LY; Lu WH; Xu SQ Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jan; 38(1):22-5. PubMed ID: 14989896 [TBL] [Abstract][Full Text] [Related]
9. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells. Li M; Song S; Lippman SM; Zhang XK; Liu X; Lotan R; Xu XC Oncogene; 2002 Jan; 21(3):411-8. PubMed ID: 11821953 [TBL] [Abstract][Full Text] [Related]
10. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma. von Rahden BH; Stein HJ; Pühringer F; Koch I; Langer R; Piontek G; Siewert JR; Höfler H; Sarbia M Cancer Res; 2005 Jun; 65(12):5038-44. PubMed ID: 15958546 [TBL] [Abstract][Full Text] [Related]
11. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells. Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952 [TBL] [Abstract][Full Text] [Related]
13. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats. Fong LY; Zhang L; Jiang Y; Farber JL J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379 [TBL] [Abstract][Full Text] [Related]
14. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Zweifel BS; Davis TW; Ornberg RL; Masferrer JL Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270 [TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139 [TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308 [TBL] [Abstract][Full Text] [Related]
17. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor. Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065 [TBL] [Abstract][Full Text] [Related]
18. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483 [TBL] [Abstract][Full Text] [Related]
19. Prognostic role of cyclooxygenase-2 expression in esophageal carcinoma. Heeren P; Plukker J; van Dullemen H; Nap R; Hollema H Cancer Lett; 2005 Jul; 225(2):283-9. PubMed ID: 15978332 [TBL] [Abstract][Full Text] [Related]
20. Expression of cyclooxygenase 2 in human malignant melanoma. Denkert C; Köbel M; Berger S; Siegert A; Leclere A; Trefzer U; Hauptmann S Cancer Res; 2001 Jan; 61(1):303-8. PubMed ID: 11196178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]